REAL-WORLD UTILIZATION AND DISCONTINUATION PATTERNS OF PCSK9 INHIBITOR USE AT A LARGE, COMMUNITY-BASED LIPID CLINIC
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(19)32387-3
Abstract: PCSK9 inhibitor (PCSK9i) use continues to rise; however, access is limited. Herein, we describe our experience at a cardiology-based community lipid clinic with a focus on payer origin and intolerance rates. Queries for the clinic… read more here.
Keywords: community; lipid clinic; pcsk9 inhibitor; cardiology ... See more keywords
Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part I: Genetics and Biochemical Parameters
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Genetics"
DOI: 10.3389/fgene.2022.849008
Abstract: Introduction: The cause of familial hypercholesterolemia (FH) is defect in LDL receptor or familial defect of apolipoprotein B-100 (FDB) or, rarely, defect in proprotein convertase subtilisin/kexin type 9. Identification and treatment of patients with FH… read more here.
Keywords: fdb; lipid clinic; retrospective analysis; mmol ... See more keywords
Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part II. Clinical Characteristics
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Genetics"
DOI: 10.3389/fgene.2022.849267
Abstract: Introduction: Patients with familial hypercholesterolemia (FH) are at increased risk of premature atherosclerotic cardiovascular disease (ASCVD). Aim of study: To perform a retrospective analysis of data to assess the effects of individual lipoproteins and other… read more here.
Keywords: ascvd; retrospective analysis; familial hypercholesterolemia; lipid clinic ... See more keywords